Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Invokana 300 mg and 100 mg tablet
Locations
1
Netherlands
University Medical Center Groningen
Groningen, Provincie Groningen, Netherlands
Start Date
June 1, 2026
Primary Completion Date
January 30, 2027
Completion Date
January 30, 2027
Last Updated
April 14, 2026
NCT06446739
NCT06884280
NCT07157397
NCT07462741
NCT07447791
NCT07106151
Lead Sponsor
University Medical Center Groningen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions